glp1 tirzepatide side effects vs Semaglutide: Which Weight Loss Medication Works Better? Avono Health | GLP-1 Explained:

Challenge 4: food aversions developing during treatment Many tirzepatide users develop unexpected food aversions

For Zepbound, rates are generally higher, with nausea affecting up to 43% of patients at the highest dose

According to their analysis, the solution contained only small concentrations of any detectable compounds

Health Conditions to Consider Some health issues need careful checking before using tirzepatide

Primarily, Mounjaro is used for blood sugar control in type 2 diabetes patients, while Zepbound is FDA-approved for promoting weight loss and weight-related complications like moderate to severe obstructive sleep apnea